CASR and type 2 diabetes mellitus: Our results highlight the physiological relevance of this DUB, indicate that OTUB1 is a relevant target protein of FIH in vivo and suggest that OTUB1 may be a novel therapeutic target for the treatment of type 2 diabetes, which needs to be investigated further in the future.